9-cis-13,14-Dihydro Retinoic Acid

IMPURITIES

Product Details

CAT No.# CS-O-14857
Category Impurities
CAS 176019-01-5
Molecular Weight 302.45
Molecular Formula C20H30O2
Purity: >98%
Synonyms: 13,14-Dihydroretinoic acid; (4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-4,6,8-trienoic acid; CS-T-53244; 9-cis-13,14-Dihydro 13-methylretinoic Acid
Application Notes: Impurity in commercial preparation of Retinoic Acid. 9-cis-13,14-Dihydroretinoic Acid, is a derivative of Retinal , corotenoid component of the visual pigments.
References: Raab, W.P., et al.: Arch. Dermatol. Res., 256, 247 (1976), Bard, D.R., Br. J. Cancer, 35, 110 (1977), Juhl, H.J., et al.: Mutat. Res., 58, 317 (1978), Ward, A., et al.: Drugs, 26, 9 (1983), Ball, et al.: Biochem. J., 42, 516 (1948), OBrien, D.F., et al.: Science, 218, 961 (1982),
Shipping: Free Shipping for worldwide on order above 2000 USD , Extra charges for Dry ice shipment 80$*
COA / MSDS:    View COA    MSDS    Enquire
The balance used are calibrated with weights traceable to National Standards NIST for accuracy
PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Benidipine D7
4. Lauroside D
5. Triazolam 13C D3
6. Icatibant impurity 1
7. BISPHENOL AF (RING-13C12)
8. 0.1% TFA in Water ULC-MS
9. Metamizole EP Impurity C HCl
10. Silodosin Metabolite D4
11. Brivaracetam Carboxylic acid metabolite [UCB 42145]
12. Terbuthylazine D5
13. tibolone (848)
14. (Z)-Dimethylvinphos
15. Silodosin Metabolite
16. 2-Phenoxymethanesulfonanilide
17. Nimesulide EP Impurity A
18. Acetone HPLC
19. Nandrolone Decanoate EP impurity F
20. N-(4-Bromophenyl)-3-methyl-N-(m-tolyl)aniline


Smileys:
CC(/C=C/C(C(C)(CCC1)C)=C1C)=C/C=C/C(C)CC(O)=O



This page contains information about 9-cis-13,14-Dihydro Retinoic Acid Cas 176019-01-5 and its Impurities.
"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."